{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:29:21Z","timestamp":1761488961941},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":9279,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1987,3]]},"abstract":"<jats:p>The antihypertensive effect of alprenolol has been studied before, during and after additional pentobarbitone treatment. The combined alprenolol\u2010pentobarbitone treatment significantly decreased alprenolol levels by 59% and 4\u2010hydroxyalprenolol by 24%. The effect was significant after three doses and declined over 4\u20105 days after pentobarbitone withdrawal. The decreased alprenolol plasma levels were associated with increased pulse rate (6%), and systolic (8%) and diastolic (9%) blood pressure. The inhibition of exercise tachycardia by alprenolol was reduced by 18% at the end of pentobarbitone treatment compared to initial monotherapy with alprenolol. The interaction is probably clinically important in those patients with hypertension and angina pectoris that are treated with barbiturates and alprenolol.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1987.tb03044.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T23:21:16Z","timestamp":1343344876000},"page":"267-271","source":"Crossref","is-referenced-by-count":4,"title":["Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension."],"prefix":"10.1111","volume":"23","author":[{"given":"P","family":"Seideman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KO","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"von Bahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01065395"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977223316"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.38.3.289"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973144part1514"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979254416"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979254423"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.37.8.804"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1974.tb00744.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558443"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979263326"},{"issue":"554","key":"e_1_2_1_12_1","first-page":"5","article-title":"The effect of the beta\u2010adrenergic blocker alprenolol in hypertension","author":"Johnsson G.","year":"1974","journal-title":"Acta med. Scand."},{"key":"e_1_2_1_13_1","unstructured":"Kylberg\u2010Hansen K.&Ervik M.(1976).Gas chromatographic determination of 4\u2010hydroxyalprenolol (H 104\/12) and alprenolol in plasma. Department of Analytical Chemistry and Biochemistry AB H\u00e4ssle S\u2010431 20 M\u00f6lndal Sweden. (Available on request)."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)96423-9"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1987.tb03044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1987.tb03044.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T20:24:56Z","timestamp":1697919896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1987.tb03044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,3]]}},"alternative-id":["10.1111\/j.1365-2125.1987.tb03044.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1987.tb03044.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,3]]}}}